Global AI in pharmaceutical Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Technology, By Application, By Geographic Coverage and By Company)
Published Date: Aug 2023 |
Format:
| No. of Pages: 215
The global market for AI in pharmaceutical industry is projected to take a leap from US$807.2 Mn recorded in 2018 to approximately US$4,451.6 Mn by 2030-end.
During 2023 - 2030, the market is projected to display a CAGR of 19.1% in terms of revenue.
By technology, the language processing segment accounts for the largest market share, whereas the drug discovery and development segment represents the largest share of the AI in pharma market, by application. driven by the need to reduce the time and cost of bringing new drugs to market. The other prominent application segments include clinical trials, patient monitoring and care, and precision medicine.
The AI in pharma market is expected to experience significant growth in North America over the next few years.
Some of the key companies operating in the AI in pharmaceutical market include GNS Healthcare, GNS Healthcare, Benevolent AI, Berg Health, Novo Nordisk, IBM Corporation, Alphabet Inc (DeepMind), General Electric Company, Pfizer Inc., Johnson & Johnson, and Novartis AG.
Buy now
Quality assured
Report Description
Research Methodology
